United European Gastroenterology Journal

Article	Citations
Portal hypertension and hepatocellular carcinoma: Navigating uncharted waters	108
Does pan‐enteric capsule endoscopy obviate magnetic resonance entero‐colonography in suspected Crohn's disease?	89
Systemic therapies in hepatocellular carcinoma: A revolution?	86
Recent developments in the management of ascites in cirrhosis	83
Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication thera	83
Transplanting severely obese cirrhotic patients: Heavy clouds still on the horizon	80
Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history	63
Temporal progression of pancreatic cancer computed tomography findings until diagnosis: A large‐scale multicenter study	63
Issue Information	57
Between progress and changing times: The journey of UEG Education Committee's chair	56
	55
Issue Information	47
Early remodeling of the colonic mucosa after allogeneic hematopoietic stem cells transplantation: An open‐label controlled pilot study on 19 patients	39
The unmet need of personalized HCC screening—Lessons learned from the Swedish nationwide registries	37
A stalk with no polyp—A muco‐submucosal elongated polyp in the duodenum	36
Effectiveness of screening endoscopy for esophageal squamous cell carcinoma in Japanese males	34
Issue Information	32
Stunned by a stone—A curious case of belly trouble	32
Medical guidelines must not be influenced by commercial interests	32
MRI Volumetric Changes in Perianal Fistulizing Crohn's Disease: Moving Toward a Novel Outcome Measure for Therapeutic Response	31
Inadequate Therapy Response on Advanced Therapy in Ulcerative Colitis Adult Patients: A Retrospective Analysis of German Health Claims Data	31
Rare Case of Mantle Cell Lymphoma With Multiple Rectal Lesions	31
Stools' donor recruitment, a challenge in pandemic times	29
	28
Gastrointestinal Guidelines app: Streamlining guideline awareness and adherence in gastroenterology	28

Young GI angle: European Specialty Examination in Gastroenterology and Hepatology exam: Tips and tricks	26
Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis	26
Structural imaging findings are related to clinical complications in chronic pancreatitis	26
	26
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study	26
The diagnostic yield of colonoscopic surveillance following resection of early age onset colorectal cancer	26
Genital warts and inflammatory bowel diseases: Danish real‐world evidence to assess patient‐relevant outcomes	26
	25
UEGWeek: The modern School of Athens	25
Issue Information	25
	24
Young GI angle: Living through a crisis: How to manage downturns in your career	24
Table of Contents	23
Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study	23
Letter of Thanks for UEG Week 2022 Reviewers	23
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?	22
Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma	22
Self‐reported treatment effectiveness for Crohn's disease using a novel crowdsourcing web‐based platform	21
UEG's prospects for the future	21
The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers	20
Risk factors associated with liver‐related complications in diabetes: There may be more than meets the eye	20
An intraprocedural bowel cleansing system for difficult‐to‐prepare patients—A multicenter prospective feasibility study	19
	19
Reducing bureaucracy in clinical trials	18
Coexistent faecal incontinence and constipation: Common but frequently overlooked	18
Corrigendum	18
Monomorphic epitheliotropic T‐cell lymphoma of the small intestine	18
Health aspects of faecal incontinence are complex and multi‐layered	18
	17
Seeing the whole picture: Inflammatory bowel disease complications and extraintestinal manifestations on cross‐sectional imaging	17
Recurrent symptoms after achalasia treatment: The value of impedance analysis	17
Association between pancreatic adenocarcinoma risk and concentration of organochlorine pesticides in adipose tissue and urine: A targeted‐screening analysis case‐control study (PESTIPAC)	17
	17
Close follow‐up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long‐term management of eosinophilic esophagitis	16
High Incidence and Impact of Suspected Exocrine Pancreatic Insufficiency in Patients Post‐Hematopoietic Stem Cell Transplantation: A Single‐Center Prospective Observational Study	16
High vaccination coverage and infection rate result in a robust SARS‐CoV‐2‐specific immunity in the majority of liver cirrhosis and transplant patients: A single‐center cross‐sectional study	16
SARS‐Cov‐2 vaccination is safe in autoimmune pancreatitis patients	16
Reporting of endoscopy and histology of ulcerative colitis in routine clinical practice: How far we are!	16
Is It Anorexia? Congenital Duodenal Web	16
Symptomatic gallstone disease: Recurrence patterns and risk factors for relapse after first admission, the RELAPSTONE study	16
“Car body appearance and engine”: The morphology‐function correlation in chronic pancreatitis	16
Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 2018	16
	16
Faecal volatile organic compounds differ according to inflammatory bowel disease sub‐type, severity, and response to treatment in paediatric patients	15
Safety of tofacitinib in IBD: A tricky puzzle	15
Colocolonic intussusception as initial manifestation of polyposis coli associated colon cancer	15
Cold versus hot polypectomy/endoscopic mucosal resection–A review of current evidence	15
Issue Information	15
Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study	15
UEG Week 2023 Oral Presentations	14

Understanding progression of strictures in ileal Crohn's disease—The importance of setting methodological standards	14
Mucosal Healing in Inflammatory Bowel Diseases: Still too Many Irons on the Fire	14
Solitary pedunculated cap polyp in a patient with ulcerative colitis	14
Selection of individuals who may benefit from pancreatic cancer surveillance	14
No evidence of association between inherited thrombophilia and increased risk of liver fibrosis	14
Post‐polypectomy surveillance colonoscopy: Comparison of the updated guidelines	13
Nodular Regenerative Hyperplasia: Report of 82 Patients and Systematic Review of Literature	13
Expanding Support Beyond Clinical Care in IBD Patients	13
Tonsillar Crohn's Disease	13
Over‐the‐scope clip versus transcatheter arterial embolization for refractory peptic ulcer bleeding—A propensity score matched analysis	13
Best of UEG Week 2024	13
UEG Week 2021 Oral Presentations	13
Benign inheritable disorders of bilirubin metabolism manifested by conjugated hyperbilirubinemia–A narrative review	13
Artificial intelligence: The researcher's assistant or sheep in wolf's clothing?	13
How to use social media for scientific advocacy and personal branding	13
Gallbladder polyps growth rate is an independent risk factor for neoplastic polyps	12
Shedding a new light on gastric cancer screening	12
German guideline diverticular disease/diverticulitis	12
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme	12
Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease	12
Recurrent bleeding in a patient with hepaticojejunostomy caused by Dieulafoy's lesion	12
Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus	12
Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study	12
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases	12
Implementation of endoscopic submucosal dissection in a country with a low incidence of gastric cancer: Results from a prospective national registry	12
Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs	12
Multi‐Omics Biomarkers for Predicting Efficacy of Biologic and Small‐Molecule Therapies in Adults With Inflammatory Bowel Disease: A Systematic Review	11
Overview of a national endoscopy database: The Trans.IT database and its impact on data registration quality	11
Translational evaluation of Gelsectan® effects on gut barrier dysfunction and visceral pain in animal models and irritable bowel syndrome with diarrhea	11
Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort	11
Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in Europ	11
Issue Information	11
Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment Outcomes	11
Addressing the overlooked psychological and social impact of fecal incontinence in inflammatory bowel disease patients	11
A rare case of squamous cell carcinoma originating from esophageal papilloma	11
The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis	10
Update on the Pancreas: Disease Mechanisms and Therapeutic Strategies	10
Post‐COVID‐19 Disorders of Gut‐Brain Interaction: A New Challenge for Gastroenterologists	10
Organoid‐based precision medicine in pancreatic cancer	10
Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure	10
The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population‐based cohort study	9
Difficult‐to‐treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment	9
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations	9
High prevalence of extended‐spectrum beta‐lactamase organisms and the COVID‐19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong	9
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study	9
Young Adult Patients With Paediatric‐Onset Inflammatory Bowel Disease Have a Higher Educational Level and a Higher Employment Rate Than the General Population	9
Exploring the links between types 2 diabetes and liver‐related complications: A comprehensive review	9
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression	9
Therapeutic management of metabolic dysfunction associated steatotic liver disease	9
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis	9
Opioid analgesia and severity of acute pancreatitis: An international multicentre cohort study on pain management in acute pancreatitis	9
Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort	9
Analysis of the burden and economic impact of digestive diseases and investigation of research gaps and priorities in the field of digestive health in the European Region—White Book 2: Executive summa	9
Inflammatory eye disease is a risk factor for future microscopic colitis: A nationwide population‐based matched case control study	9
Clinical management of patients with drug‐induced liver injury (DILI)	8
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutri	8
Epithelial neutrophil localization and tight junction Claudin‐2 expression are innovative outcome predictors in inflammatory bowel disease	8
Issue Information	8
Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register	8
Four‐fold increased mortality rate in patients with Wilson's disease: A population‐based cohort study of 151 patients	8
The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries	8
Issue Information	8
	8
Long‐Term Mortality in Acute Pancreatitis—A Population‐Based Cohort Study	8
Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies	8
Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome	8
Real‐world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey	8
A milestone in screening for adherent‐invasive E. coli colonization in patients with Crohn’s disease?	8
Letter of Thanks for UEG Week 2024 Reviewers	8
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management	8
Update on Autoimmune Pancreatitis and IgG4‐Related Disease	7
	7
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure	7
Young GI angle: How to recognize a predatory journal	7
Duodenal Ablation Under the Spotlight of Science: A Promising Approach With Open Questions	7
Irritable bowel syndrome: Factors of importance for disease‐specific quality of life	7
	7
Raising interest for neurogastroenterology: Bottom‐up from the undergraduate medical curriculum?	7
Pancreatic Neuroendocrine Neoplasms: Classification and Novel Role of Endoscopic Ultrasound in Diagnosis and Treatment Personalization	7
Prior hospital‐based infection and risk of eosinophilic esophagitis in a Swedish nationwide case‐control study	7

European Consensus on Malabsorption—UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: Definitions, Clinical Phenotypes, and Diagnostic Testing for Malabsorption	7
Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice—Real‐world evidence from the inflammatory bowel diseases‐podcast study	7
The Pivotal ‘P’s of inflammatory bowel disease: Prediction and Prevention	6
Acknowledgements	6
Correction to “A portrait of Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound training programs in Europe: Current practices and opportunities for improvement”	6
The Workgroup Serrated Polyps and Polyposis (WASP) classification for optical diagnosis of colorectal diminutive polyps with iScan and the impact of the revised World Health Organization (WHO) criteri	6
Autoimmune pancreatitis—New evidence for clinical management strategies	6
	6
Quality of clinical guidelines: It matters as it impacts patient care	6
Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta‐analysis	6
How safe are opioids in the early phase of acute pancreatitis?	6
Young GI angle: Imposter syndrome: What a young GI should know	6
Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?	6
	6
How to get new guidelines in United European Gastroenterology: Follow the gold!	6
Serum Biomarkers of Extracellular Matrix Remodeling in Ulcerative Colitis—One Step Closer to Fibrosis Biomarkers in Inflammatory Bowel Disease	6
New German guidelines for the management of diverticulitis	6
Issue Information	6
Metabolic dysfunction associated steatotic liver disease—Clinicians should not underestimate the role of steatosis	6
UEG Journal's impact and vision for the future	6
Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population‐based cohort studies	6
Intra‐abdominal abscesses in CD – When to treat with biologics?	6
Comments on Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes: Authors' reply	5
Guideline for the assessment and management of gastrointestinal symptoms following colorectal surgery—A UEG/ESCP/EAES/ESPCG/ESPEN/ESNM/ESSO collaboration. Part II—Good practice guidance | sequelae to	5
Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma	5
European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendatio	5
Issue Information	5
	5
The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program	5
Patient preferences for the diagnosis of coeliac disease: A discrete choice experiment	5
Association of circulating Z‐polymer with adverse clinical outcomes and liver fibrosis in adults with alpha‐1 antitrypsin deficiency	5
An unusual case of multiple colonic polyps	5
COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry	5
Prediction of metachronous advanced colorectal neoplasia by KRAS mutation in polyps	5
Issue Information	5
Thrombolysis for haemobilia‐induced biliary obstruction through a cholangiodrainage catheter	5
	5
Prevalence of stricturing, penetrating complications and extraintestinal manifestations in inflammatory bowel disease detected on cross‐sectional imaging in a tertiary care setting	5
Young GI angle: Challenges in education of liver transplantation gastroenterologists	5
The Japanese Esophageal Society classification for prediction of superficial esophageal squamous cell neoplasia invasion depth: Validation in a Western population	5
Dietary strategies in non‐alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review	5
miR‐10b‐5p rescues leaky gut linked with gastrointestinal dysmotility and diabetes	5
Issue Information	5
T1 Colorectal Cancer: What Are the Barriers to Minimizing Unnecessary Surgical Interventions?	5
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease	4
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives	4
Gastrointestinal Perforations Associated With JAK Inhibitors: A Disproportionality Analysis of the FDA Adverse Event Reporting System	4
Interferential therapy for chronic constipation in adults: The CON‐COUR randomizedcontrolled trial	4
	4
Can we predict the future of patients with liver cirrhosis using volumetrics?	4
Preclinical IBD: One more piece of the puzzle	4
Issue Information	4
Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease	4
	4
Join the myUEG community and become an official myUEG Associate for free	4
Surveillance of Barrett's Esophagus Patients in an Expert Center is Associated With Low Disease‐Specific Mortality	4
Risk factors for the occurrence of ampullary tumors: A case‐control study	4
Re: European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients	4
	4
Young GI angle: Networking in gastroenterology—How to expand your possibilities with the UEG?	4
The natural history of extraintestinal manifestations after surgery in inflammatory bowel disease: Never give up!	4
Issue Information	4
Prognosis of variceal and non‐variceal upper gastrointestinal bleeding in already hospitalised patients: Results from a French prospective cohort	4
Morbid obesity increases death and dropout from the liver transplantation waiting list: A prospective cohort study	4
The guts of the matter: UEG's role in European Union health policy developments	4
Drug Interaction With Advanced Therapies in Inflammatory Bowel Diseases: A Blind Spot to Tackle	4
Increased risk of genital warts in inflammatory bowel disease: A Danish registry‐based cohort study (1996–2018)	4
Elective percutaneous liver biopsy and use of aspirin	4
Corrigendum	4
	4
	4
Issue Information	4
CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma	4
T1 colorectal cancer patients' perspective on information provision and therapeutic decision‐making after local resection	3
Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis—Results from the population‐based DanEoE cohort shows a low complication rate	3
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study	3
Prospective Evaluation of Real‐Time Artificial Intelligence for the Hill Classification of the Gastroesophageal Junction	3
Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance	3
Role of probiotics in preventing adverse events related to Helicobacter pylori treatment	3
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia	3
Guideline for the diagnosis and treatment of Faecal Incontinence—A UEG/ESCP/ESNM/ESPCG collaboration	3
Endoscopic Techniques for Colorectal Neoplasia Surveillance in Inflammatory Bowel Disease: A Systematic Review and Network Meta‐Analysis	3
German guideline diverticular disease/diverticulitis	3
Guideline for the assessment and management of gastrointestinal symptoms following colorectal surgery—A UEG/ESCP/EAES/ESPCG/ESPEN/ESNM/ESSO collaboration. Part I—Sequelae to oncological diseases	3
The assessment and management of cirrhotic patients with encephalopathy	3
Real‐time use of artificial intelligence (CADEYE) in colorectal cancer surveillance of patients with Lynch syndrome—A randomized controlled pilot trial (CADLY)	3
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study	3
Prevalence of COVID‐19 in patients with autoimmune liver disease in Europe: A patient‐oriented online survey	3
How to raise the interest for neurogastroenterology among young gastroenterologists?	3
Influence of sex in alcohol‐related liver disease: Pre‐clinical and clinical settings	3
Modifying Our Environment to Improve Outcomes in Inflammatory Bowel Diseases?	3
UEG Week 2022 Oral Presentations	3
Tofacitinib in chronic pouchitis: A step towards addressing an unmet need	3
Gastric cancer detection by non‐blood‐based liquid biopsies: A systematic review looking into the last decade of research	3
Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study	3